Cochrane Review: Gonadotropin-releasing hormone analogues for endometriosis

Zusammenfassung

Gonadotropin‐Releasing‐Hormon‐Analoga bei Endometriose - Veth, VB - 2023 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014788.pub2/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014788.pub2/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish

Kerninformationen

](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background Endometriosis is a common gynaecological condition affecting 6 to 11% of reproductive‐age women and may cause dyspareunia, dysmenorrhoea, and...

options. ### Objectives To assess the effectiveness and safety of GnRH analogues (GnRHas) in the treatment of painful symptoms associated with endometriosis and to determine the effects of GnRHas on bone mineral density of women with endometriosis. ### Search methods We searched the Cochrane Gy...

ompared with no treatment or placebo. Trials comparing GnRHas versus GnRHas in conjunction with add‐back therapy (hormonal or non‐hormonal) or calcium‐regulation agents were also included in this review. ### Data collection and analysis We used standard methodology as recommended by Cochrane. Prim...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen